#6 - Cardinal Health (NYSE:CAH)
The healthcare sector is another logical sector for investors to hide out in when interest rates are rising. Individuals will prioritize health care right along with consumer staples. Cardinal Health, Inc. (NYSE: CAH) has an expansive mission as “a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities.”
That simply means the company is involved at every stage of a patient and provider’s healthcare journey. And the company is showing some impressive fundamentals. At a time when earnings are expected to decline, Cardinal has beaten earnings expectations in the last two quarters and is expecting to post higher full-year earnings in 2023.
That corresponds to the 39% growth in the CAH stock price. The company is also a dividend aristocrat that pays a respectable dividend yield of 2.07% and has been increasing its dividend for the last 37 years. Cardinal Health sports 88% institutional ownership which helps make the stock less volatile.
About Cardinal Health
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Read More - Current Price
- $118.28
- Consensus Rating
- Moderate Buy
- Ratings Breakdown
- 8 Buy Ratings, 5 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- $127.50 (7.8% Upside)
